PEMAX™ a double dye technology (Patent pending) developed by GenIUL in order to overcome the current limitations of viability PCR procedures. Nowadays, the paradigm is based in the cell membrane integrity of living cells as a unique differential factor from dead cells. However, as appointed in first reports, some treatment procedures can induce cells death without compromising membrane integrity.
This new reagent, combined with the appropriate reaction buffer, extends the concept of viability PCR to cells with intact cell membrane structure but also with capability to actively maintain bacterial homeostasis, as a result of active metabolism.
The Kit for TBC-Biomarker has been developed to monitoring the disease status in clinical samples (Research Use Only)